Sector consensus Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 04:00:00 2026-07-31 pm EDT			5-day change	1st Jan Change
16.52 ^USD	-27.16%		-27.48%	+5.36%

Jul. 31	Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial	MT
Jul. 31	Wedbush Adjusts Monte Rosa Therapeutics Price Target to $27 From $37, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
MONTE ROSA THERAPEUTICS, INC.	32.33	+95.72%	6
LONZA GROUP AG	680.7	+21.08%	23
REVOLUTION MEDICINES, INC.	207	+10.38%	21
IQVIA HOLDINGS INC.	272.94	+16.14%	18
BEONE MEDICINES AG	415.64	+31.53%	27
CELLTRION, INC.	265,216.27	+42.05%	24
ASCENDIS PHARMA A/S	267.77	+24.82%	18
MEDPACE HOLDINGS, INC.	581.83	+0.82%	12
EUROFINS SCIENTIFIC SE	72.53	+6.41%	14
ICON PUBLIC LIMITED COMPANY	184.62	+12.88%	16
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	228.5	-1.72%	14
BIO-TECHNE CORPORATION	69.73	-3.28%	11
ABIVAX	138.56	+30.35%	6
APOGEE THERAPEUTICS, INC.	130.53	-2.66%	12
PROTAGONIST THERAPEUTICS, INC.	133.31	-2.44%	13
PHARMARON BEIJING CO., LTD.	37.73	+2.53%	11
IONIS PHARMACEUTICALS, INC.	89.14	+72.19%	21
KYMERA THERAPEUTICS, INC.	127.18	+23%	22
PRAXIS PRECISION MEDICINES, INC.	610.05	+98.18%	19
QIAGEN N.V.	44.07	+6.45%	14
Average	13,477.02	+24.22%	16
Weighted average by Cap.	23,051.68	+20.66%	19